Overview
- Species: Human
- Keywords: iPSC-derived cells
- iPSC: iPSC-Derived Myoblasts
- Features: cryopreserved, male
- Cell Type: Muscle Cells
Cat.-Nr.: ASE-9706
Description
Take advantage of 25% off on these iPSC-derived Cells with Media – offer ends December 31, 2025
Applied StemCell has developed an efficient integration-free method to differentiate high-quality myoblasts from human iPSCs, with further differentiation into myotubes and skeletal muscle cells. The differentiated myoblasts recapitulate the phenotype and functional parameters of primary and in vivo myoblasts.
We provide cryopreserved myoblasts differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from fibroblasts of an African American male donor. These cryopreserved, high-purity (>90%) cells express high levels of myoblast biomarkers (CD56, Pax7, Myogenin) and form mature myotubes (skeletal muscle) characterized by elongated, multi-nucleated structures and the expression of myotube marker alpha-MHC in 4-6 days.
These iPSC-differentiated myoblasts/myotubes can be used as control lines to compare the phenotype and functionality of patient-derived and genome-edited iPSC-derived myoblasts/myotubes, for co-culture models with motor neurons (ASE-9701), and for toxicity and drug screening.
These iPSC-derived cells are available from the following donors:
– Normal, Male, African American, Neonate, from Fibroblasts (#ASE-9211)
– Normal, Male, Caucasian, Age 39, from Fibroblasts
Please contact us for more information.
SUPPLIER:
Applied StemCell
STATUS:
In Stock
SIZE:
kit